(Q34346199)

1 August 2017

1 reference

title

Cancer genetics in oncology practice (English)

1 reference

1 August 2017

O I Olopade

1

1 reference

1 August 2017

G Pichert

series ordinal

2

1 reference

1 August 2017

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

895-908

1 reference

Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Breast cancer genetics in an oncology clinic: 328 consecutive patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Age at onset as an indicator of familial risk of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

A computer program for estimating individualized probabilities of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Linkage of early-onset familial breast cancer to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Breast cancer genes and DNA repair.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

In search of the tumour-suppressor functions of BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

A large multisite cancer family is linked to BRCA2.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Gene-Expression Profiles in Hereditary Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Subcutaneous mastectomy is not a prophylaxis against carcinoma of the breast: opinion or knowledge?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Technical considerations for prophylactic mastectomy in patients at high risk for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Breast cancer risk associated with gynecologic surgery and indications for such surgery

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Breast cancer visualized by mammography in patients under 35

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Mammography in Asian patients with BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Hereditary gastrointestinal polyposis and nonpolyposis syndromes.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Cancer risk in relatives of patients with common colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Family history of cancer and colon cancer risk: the Utah Population Database

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Familial risk and colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Colorectal cancer screening: clinical guidelines and rationale

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Alleles of the APC gene: an attenuated form of familial polyposis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Identification of FAP locus genes from chromosome 5q21

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Molecular diagnosis of familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

The use and interpretation of commercial APC gene testing for familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Familial adenomatous polyposis: efficacy of endoscopic and surgical treatment for advanced duodenal adenomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

The protocol for a european double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: The capp study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Genetic mapping of a locus predisposing to human colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Mutation of a mutL homolog in hereditary colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Microsatellite instability in cancer of the proximal colon

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Rectal Cancer Risk in Hereditary Nonpolyposis Colorectal Cancer After Abdominal Colectomy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Cancer risk associated with germline DNA mismatch repair gene mutations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Gynecologic cancer clues to Lynch syndrome II diagnosis: a family report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Genetic testing in families with hereditary nonpolyposis colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II Demonstration Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011176107455

7 January 2021

Identifiers

DOI

10.1023/A:1011176107455

1 reference

1 August 2017

1 reference